New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:23 EDTSNSS, DNDNSunesis appoints Joseph DePinto as Chief Commercial Officer
Sunesis Pharmaceuticals (SNSS) announced the appointment of Joseph DePinto to the newly created position of executive vice president and Chief Commercial Officer. Prior to joining Sunesis, DePinto was Executive Vice President, Global Commercial Operations at Dendreon (DNDN).
News For SNSS;DNDN From The Last 14 Days
Check below for free stories on SNSS;DNDN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 29, 2014
10:18 EDTSNSSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:01 EDTSNSSSunesis downgraded to Neutral from Outperform at Wedbush
Wedbush downgraded Sunesis citing valuation.
06:14 EDTSNSSSunesis implied volatility of 255 at upper end of index mean range
Subscribe for More Information
August 28, 2014
06:31 EDTSNSSSunesis volatility increases on price movement
Subscribe for More Information
August 27, 2014
16:28 EDTSNSSOn The Fly: Closing Wrap
Subscribe for More Information
15:41 EDTSNSSSunesis rises ahead of critical trial data
Subscribe for More Information
07:56 EDTSNSSStreet too cautious about upcoming Sunesis VALOR data, says UBS
Subscribe for More Information
August 19, 2014
13:00 EDTDNDNDendreon alternatives could leave no equity value, says Brean Capital
Subscribe for More Information
August 18, 2014
10:43 EDTSNSSHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use